Pulmonary tularemia leading to a relapse of tularemia orchitis in a patient on TNF-alpha inhibitor
- 13 July 2026
- journal article
- case report
- Published by Springer Nature in Wiener klinische Wochenschrift
- p. 1-5
Abstract
Summary Purpose Tularemia represents a zoonotic infection that poses particular diagnostic and therapeutic challenges in immunocompromised patients. We present a rare case of tularemia orchitis in a patient receiving tumor necrosis factor alpha (TNF alpha) inhibitor treatment. Methods We conducted a case analysis of a 71-year-old farmer receiving adalimumab for psoriatic arthritis who developed sequential pulmonary and genitourinary manifestations of tularemia. Clinical presentation, laboratory findings, microbiological identification through culture and polymerase chain reaction testing, imaging studies, and histopathological examination were documented. Treatment response and clinical follow-up were monitored throughout the disease course. Results The patient initially presented with pneumonic tularemia confirmed by positive blood cultures. Following apparent clinical resolution with doxycycline therapy, he developed orchitis 3 months later requiring unilateral orchiectomy. Polymerase chain reaction testing confirmed Francisella tularensis as the causative pathogen in testicular tissue. Histological examination revealed dense inflammatory infiltration with histiocytes, neutrophils, and T‑lymphocytes. Combination therapy with doxycycline and ciprofloxacin achieved clinical remission, although fluoroquinolone-induced peripheral neuropathy necessitated treatment modification. Conclusion Patients receiving tumor necrosis factor alpha inhibitors demonstrate increased susceptibility to tularemia manifestations and potential disease relapse. The blood-testis barrier may limit antibiotic penetration, contributing to treatment failure with monotherapy. Enhanced clinical awareness and consideration of combination antimicrobial therapy may be warranted in immunocompromised patients with tularemia, particularly those residing in endemic regions.Keywords
This publication has 16 references indexed in Scilit:
- Tularemia treatment: experimental and clinical dataFrontiers in Microbiology, 2024
- Three Cases of Tickborne Francisella tularensis Infection, Austria, 2022Emerging Infectious Diseases, 2023
- Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica , AustriaEmerging Infectious Diseases, 2023
- The Mammalian Blood-Testis Barrier: Its Biology and RegulationEndocrine Reviews, 2015
- Peripheral neuropathy and Guillain-Barré syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysisAnnals of Epidemiology, 2014
- Epidemiology of TularemiaBalkan Medical Journal, 2014
- Rates of serious infection, including site‐specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2006
- Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice.1999
- Penetration of Ciprofloxacin into Prostatic Fluid, Ejaculate and Seminal Fluid in Volunteers after an Oral Dose of 750 MGJournal of Urology, 1993
- Antimicrobial Tissue Penetration in a Rat Model of E. Coli EpididymitisJournal of Urology, 1991